Overview and Future Potential of Buccal Mucoadhesive Films as Drug Delivery Systems for Biologics

AAPS PharmSciTech

Volumn 18, Issue 1, 2017, Pages 3-14

  Montenegro Nicolini, Miguel ^a,b   Morales, Javier O ^a,c  

^a UNIVERSITY OF CHILE   (Chile)

^b INSTITUTO DE SALUD PÚBLICA DE CHILE   (Chile)

^c University of Chile   (Chile)

Author keywords

biologics; buccal delivery; casting; hot melt extrusion; inkjet printing

Indexed keywords

BILE SALT; BIOLOGICAL PRODUCT; FATTY ACID; PLASTICIZER; POLYMER; SOLVENT; SURFACTANT;

ARTICLE; CHEEK MUCOSA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; FILM; FIRST PASS EFFECT; GASTROINTESTINAL TRACT; MOLECULE; MUCOADHESION; PRINTING; PRIORITY JOURNAL; ADHESION; ANIMAL; BUCCAL DRUG ADMINISTRATION; CHEMISTRY; HUMAN; MEDICINAL CHEMISTRY; METABOLISM; MOUTH MUCOSA; PROCEDURES;

ADHESIVENESS; ADMINISTRATION, BUCCAL; ANIMALS; BIOLOGICAL PRODUCTS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; HUMANS; MOUTH MUCOSA; POLYMERS;

EID: 84963778363     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-016-0525-z     Document Type: Article

References (127)

1. Castán H, Ruiz MA, Clares B, Morales ME. Design, development and characterization of buccal bioadhesive films of Doxepin for treatment of odontalgia. Drug Deliv. 2015;22(6):869–76. doi:10.3109/10717544.2014.896958
2. Costa IDM, Abranches RP, Garcia MTJ, Pierre MBR. Chitosan-based mucoadhesive films containing 5-aminolevulinic acid for buccal cancer’s treatment. J Photochem Photobiol B. 2014;140:266–75.
3. Morales JO, McConville JT. Novel strategies for the buccal delivery of macromolecules. Drug Dev Ind Pharm. 2014;40:579–90.
4. Castro PM, Fonte P, Sousa F, Madureira AR, Sarmento B, Pintado ME. Oral films as breakthrough tools for oral delivery of proteins/peptides. J Control Release. 2015;211:63–73.
5. Chhina M. Overview of biological products. Center for Drug Evaluation and Research U.S. Food and Drug Administration FDA Webinar; 2013.
6. Zhao L, Ren T, Wang DD. Clinical pharmacology considerations in biologics development. Acta Pharmacol Sin. 2012;33:1339–47.
7. Abruzzo A, Bigucci F, Cerchiara T, Cruciani F, Vitali B, Luppi B. Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride. Carbohydr Polym. 2012;87:581–8.
8. Senel S, Kremer M, Nagy K, Squier C. Delivery of bioactive peptides and proteins across oral (buccal) mucosa. Curr Pharm Biotechnol. 2001;2:175–86.
9. Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm. 2011;77:187–99.
10. MonoSol Rx. MonoSol Rx and the PharmFilm pipeline. 2015. http://www.monosolrx.com/content/pipeline/overview.htm. Accessed 16 Nov 2015.
11. Muheem A, Shakeel F, Jahangir MA, Anwar M, Mallick N, Jain GK, et al. A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi Pharm J. 2014. doi:10.1016/j.jsps.2014.06.004.
12. Klein P, Kanehisa M, DeLisi C. Prediction of protein function from sequence properties. Discriminant analysis of a data base. Biochim Biophys Acta. 1984;787:221–6.
13. Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov. 2008;7:21–39.
14. Park K, Kwon IC, Park K. Oral protein delivery: current status and future prospect. React Funct Polym. 2011;71:280–7.
15. Genetic Engineering & Biotechnology News The Top 25 Best-Selling Drugs of 2014 | Insight & Intelligence™ In: G. E. N. http://www.genengnews.com/insight-and-intelligence/the-top-25-best-selling-drugs-of-2014/77900383/?kwrd=top%20selling%20drugs&page=2. Accessed 24 Nov 2015.
16. Voet D. Biochemistry. J. Wiley & Sons: New York; 1995.
17. Nehete JY, Bhambar RS, Narkhede MR, Gawali SR. Natural proteins: sources, isolation, characterization and applications. Pharmacogn Rev. 2013;7:107–16.
18. Pihlasalo S, Auranen L, Hänninen P, Härmä H. Method for estimation of protein isoelectric point. Anal Chem. 2012;84:8253–8.
19. Trevino SR, Scholtz JM, Pace CN. Measuring and increasing protein solubility. J Pharm Sci. 2008;97:4155–66.
20. Arakawa T, Timasheff SN. Theory of protein solubility. Methods Enzymol. 1985;114:49–77.
21. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 1988;29:1035–41.
22. Mudie DM, Murray K, Hoad CL, Pritchard SE, Garnett MC, Amidon GL, et al. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. Mol Pharm. 2014;11:3039–47.
23. Fallingborg J, Christensen LA, Ingeman-Nielsen M, Jacobsen BA, Abildgaard K, Rasmussen HH. pH-profile and regional transit times of the normal gut measured by a radiotelemetry device. Aliment Pharmacol Ther. 1989;3:605–13.
24. Bratten J, Jones MP. Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system. J Clin Gastroenterol. 2009;43:527–33.
25. Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature. 1994;368:563–6.
26. Hwang SR, Byun Y. Advances in oral macromolecular drug delivery. Expert Opin Drug Deliv. 2014;11:1955–67.
27. Artursson P, Ungell AL, Löfroth JE. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm Res. 1993;10:1123–9.
28. Nanci A. Ten Cate’s oral histology: development, structure, and function. Elsevier: St. Louis; 2008
29. McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm. 2008;364:213–26.
30. Lee HJ. Protein drug oral delivery: the recent progress. Arch Pharm Res. 2002;25:572–84.
31. Zhou XH. Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs. J Control Release. 1994;29:239–52.
32. Smart AL, Gaisford S, Basit AW. Oral peptide and protein delivery: intestinal obstacles and commercial prospects. Expert Opin Drug Deliv. 2014;11:1323–35.
33. Lee S, Lee J, Lee DY, Kim SK, Lee Y, Byun Y. A new drug carrier, Nalpha-deoxycholyl-L: -lysyl-methylester, for enhancing insulin absorption in the intestine. Diabetologia. 2005;48:405–11.
34. Pond SM, Tozer TN. First-pass elimination. Basic concepts and clinical consequences. Clin Pharmacokinet. 1984;9:1–25.
35. Rowland M. Influence of route of administration on drug availability. J Pharm Sci. 1972;61:70–4.
36. Chap Z, Ishida T, Chou J, Hartley CJ, Entman ML, Brandenburg D, et al. First-pass hepatic extraction and metabolic effects of insulin and insulin analogues. Am J Phys Endocrinol Metab. 1987;252:E209–17.
37. Bae SK, Yang KH, Aryal DK, Kim YG, Lee MG. Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect. J Pharm Sci. 2009;98:1587–601.
38. Yanamandra S, Venkatesan N, Kadajji VG, Wang Z, Issar M, Betageri GV. Proliposomes as a drug delivery system to decrease the hepatic first-pass metabolism: case study using a model drug. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2014;64:26–36.
39. Squier CA, Cox P, Wertz PW. Lipid content and water permeability of skin and oral mucosa. J Invest Dermatol. 1991;96:123–6.
40. Hearnden V, Sankar V, Hull K, Juras DV, Greenberg M, Kerr AR, et al. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev. 2012;64:16–28.
41. Patil PC. Oral fast dissolving drug delivery system: a modern approach for patient compliance. Int J Drug Regul Aff. 2014;2(2):49–60.
42. Emedicine.medscape.com. Mouth Anatomy: Overview, Gross Anatomy: Oral Vestibule, Gross Anatomy: Oral Cavity Proper. 2016. [online] Available at: http://emedicine.medscape.com/article/1899122-overview. Accessed 5 Feb 2016.
43. Arya S, Rane P, Deshmukh A. Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management. Clin Radiol. 2014;69:916–30.
44. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. J Control Release. 2006;114:15–40.
45. Gandhi RB, Robinson JR. Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev. 1994;13:43–74.
46. Tayal S, Jain N. Buccal control drug delivery system: a review. Int J Pharm Sci Res. 2011;2:13.
47. Squier CA. The permeability of keratinized and nonkeratinized oral epithelium to horseradish peroxidase. J Ultrastruct Res. 1973;43:160–77.
48. Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers—how do they really work? J Control Release. 2005;105:1–15.
49. Bhati R, Nagrajan RK. A detailed review on oral mucosal drug delivery system. Int J Pharm Sci Res. 2012;3:659–81.
50. Silva BMA, Borges AF, Silva C, Coelho JFJ, Simões S. Mucoadhesive oral films: the potential for unmet needs. Int J Pharm. 2015;494:537–51.
51. Research C for DE and Data Standards Manual (monographs) - Dosage Form. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/DataStandardsManualmonographs/ucm071666.htm. Accessed 14 Mar 2015.
52. Preis M, Knop K, Breitkreutz J. Mechanical strength test for orodispersible and buccal films. Int J Pharm. 2014;461:22–9.
53. Europe C of, European Pharmacopoeia Commission, European Directorate for the Quality of Medicines & Healthcare (2014) European Pharmacopoeia, 8th edition. Council Of Europe: European Directorate for the Quality of Medicines and Healthcare, Strasbourg.
54. Jones E, Ojewole E, Kalhapure R, Govender T. In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy. Drug Dev Ind Pharm. 2014;40:669–79.
55. Buanz ABM, Belaunde CC, Soutari N, Tuleu C, Gul MO, Gaisford S. Ink-jet printing versus solvent casting to prepare oral films: effect on mechanical properties and physical stability. Int J Pharm. 2015;494:611–8.
56. Jeong SH, Lee J, Woo JS. Fast disintegrating tablets. In: Wen H, Park K (eds) Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice. John Wiley & Sons, Inc.: Hoboken. 2010. doi:10.1002/9780470640487.ch10
57. Saigal N, Baboota S, Ahuja A, Ali J. Fast-dissolving intra-oral drug delivery systems. Expert Opin Ther Pat. 2008;18:769–81.
58. Udhan RR, Chavan V, Tribhuvan N. Mouth dissolving film and their patent: an overview. Int Reserach J Pharm. 2012;3(9):39–42.
59. Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv. 2011;8:299–316.
60. Dexter AF, Malcolm AS, Middelberg APJ. Reversible active switching of the mechanical properties of a peptide film at a fluid–fluid interface. Nat Mater. 2006;5:502–6.
61. de Barros JMS, Scherer T, Charalampopoulos D, Khutoryanskiy VV, Edwards AD. A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria. J Pharm Sci. 2014;103:2022–32.
62. Dawson PL, Hirt DE, Rieck JR, Acton JC, Sotthibandhu A. Nisin release from films is affected by both protein type and film-forming method. Food Res Int. 2003;36:959–68.
63. Padgett T, Han IY, Dawson PL. Incorporation of food-grade antimicrobial compounds into biodegradable packaging films. J Food Prot. 1998;61:1330–5.
64. Giovino C, Ayensu I, Tetteh J, Boateng JS. An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles. Colloids Surf B: Biointerfaces. 2013;112:9–15.
65. Giovino C, Ayensu I, Tetteh J, Boateng JS. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Int J Pharm. 2012;428:143–51.
66. Morales JO, Huang S, Williams RO, McConville JT. Films loaded with insulin-coated nanoparticles (ICNP) as potential platforms for peptide buccal delivery. Colloids Surf B: Biointerfaces. 2014;122:38–45.
67. Colonna C, Genta I, Perugini P, Pavanetto F, Modena T, Valli M, et al. 5-Methyl-pyrrolidinone chitosan films as carriers for buccal administration of proteins. AAPS PharmSciTech. 2006;7:E107–13.
68. Kundu J, Patra C, Kundu SC. Design, fabrication and characterization of silk fibroin-HPMC-PEG blended films as vehicle for transmucosal delivery. Mater Sci Eng C. 2008;28:1376–80.
69. Li C, Koch RL, Raul VA, Bhatt PP, Johnston TP. Absorption of thyrotropin-releasing hormone in rats using a mucoadhesive buccal patch. Drug Dev Ind Pharm. 1997;23:239–46.
70. Sushma M, Raju YP, Sundaresan CR, Vandana KR, Kumar NV, Chowdary VH. Transmucosal delivery of metformin—a comprehensive study. Curr Drug Deliv. 2014;11:172–8.
71. Maniruzzaman M, Boateng JS, Snowden MJ, Douroumis D. A review of hot-melt extrusion: process technology to pharmaceutical products. Expert Opin Drug Deliv. 2016;13(4):493–506. doi:10.1517/17425247.2016.1118048
72. Parikh T, Gupta SS, Meena AK, Vitez I, Mahajan N, Serajuddin ATM. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate. J Pharm Sci. 2015;104:2142–52.
73. Buanz ABM, Saunders MH, Basit AW, Gaisford S. Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing. Pharm Res. 2011;28:2386–92.
74. Londhe VY, Umalkar KB. Formulation development and evaluation of fast dissolving film of telmisartan. Indian J Pharm Sci. 2012;74:122–6.
75. Lindén M. Hot-melt extrusion of modified release pellets-influence of the formulation and extrusion process on extended-and enteric release profile. 2012.
76. Sahni J, Raj S, Ahmad FJ, Khar RK. Design and in vitro characterization of buccoadhesive drug delivery system of insulin. Indian J Pharm Sci. 2008;70:61–5.
77. Park J-B, Prodduturi S, Morott J, Kulkarni VI, Jacob MR, Khan SI, et al. Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology. Expert Opin Drug Deliv. 2015;12:1–13.
78. Scoutaris N, Alexander MR, Gellert PR, Roberts CJ. Inkjet printing as a novel medicine formulation technique. J Control Release. 2011;156:179–85.
79. Repka MA, Munjal M, ElSohly MA, Ross SA. Temperature stability and bioadhesive properties of δ9-tetrahydrocannabinol incorporated hydroxypropylcellulose polymer matrix systems. Drug Dev Ind Pharm. 2006;32:21–32.
80. Arrabito G, Pignataro B. Inkjet printing methodologies for drug screening. Anal Chem. 2010;82:3104–7.
81. Krampe R, Visser JC, Frijlink HW, Breitkreutz J, Woerdenbag HJ, Preis M. Oromucosal film preparations: points to consider for patient centricity and manufacturing processes. Expert Opin Drug Deliv. 2015;1–14.
82. Zhang Y, Cui L, Che X, Zhang H, Shi N, Li C, et al. Zein-based films and their usage for controlled delivery: origin, classes and current landscape. J Control Release. 2015;206:206–19.
83. Siemann U. Solvent cast technology—a versatile tool for thin film production. In: Scatt. Methods Prop. Polym. Mater. Springer; 2005. pp 1–14.
84. Maniruzzaman M, Boateng JS, Snowden MJ, Douroumis D. A review of hot-melt extrusion: process technology to pharmaceutical products. ISRN Pharm. 2012.
85. Repka MA, Gutta K, Prodduturi S, Munjal M, Stodghill SP. Characterization of cellulosic hot-melt extruded films containing lidocaine. Eur J Pharm Biopharm. 2005;59:189–96.
86. Jedinger N, Schrank S, Fischer JM, Breinhälter K, Khinast J, Roblegg E. Development of an abuse- and alcohol-resistant formulation based on hot-melt extrusion and film coating. AAPS PharmSciTech. 2015. doi:10.1208/s12249-015-0373-2.
87. Mueannoom W, Srisongphan A, Taylor KMG, Hauschild S, Gaisford S. Thermal ink-jet spray freeze-drying for preparation of excipient-free salbutamol sulphate for inhalation. Eur J Pharm Biopharm. 2012;80:149–55.
88. Wijshoff H. Structure- and fluid-dynamics in piezo inkjet printheads. Enschede: University of Twente [Host]; 2008.
89. Daly R, Harrington TS, Martin GD, Hutchings IM Inkjet printing for pharmaceutics—a review of research and manufacturing. Int J Pharm. doi: 10.1016/j.ijpharm.2015.03.017.
90. Houlgrave S, LaPorte GM, Stephens JC, Wilson JL. The classification of inkjet inks using accutof™ dart™ (direct analysis in real time) mass spectrometry—a preliminary study. J Forensic Sci. 2013;58:813–21.
91. Essel JT, Ihnen AC, Carter JD. Production of naproxen nanoparticle colloidal suspensions for inkjet printing applications. Ind Eng Chem Res. 2014;53:2726–31.
92. Genina N, Fors D, Palo M, Peltonen J, Sandler N. Behavior of printable formulations of loperamide and caffeine on different substrates—effect of print density in inkjet printing. Int J Pharm. 2013;453:488–97.
93. Genina N, Janßen EM, Breitenbach A, Breitkreutz J, Sandler N. Evaluation of different substrates for inkjet printing of rasagiline mesylate. Eur J Pharm Biopharm. 2013;85:1075–83.
94. Delaney JT, Smith PJ, Schubert US. Inkjet printing of proteins. Soft Matter. 2009;5:4866.
95. Blum L, Coulet P. Biosensor principles and applications. Marcel Dekker Inc.: New York; 1991.
96. Zheng Q, Lu J, Chen H, Huang L, Cai J, Xu Z. Application of inkjet printing technique for biological material delivery and antimicrobial assays. Anal Biochem. 2011;410:171–6.
97. Montenegro-Nicolini M, Miranda V, Toro E, Morales JO. The use of inkjet printing for dosing biomacromolecular actives in drug delivery systems. Conference presentation at 42nd Annual Meeting & Exposition of the Controlled Release Society. Scotland: Edinburgh; 2015.
98. Bozkir A. Investigation of the stability with bracketing design in tablet form. Pharm Anal Acta. 2011. doi:10.4172/2153-2435.S1-005.
99. Singh J, Unlu Z, Ranganathan R, Griffiths P. Aggregate properties of sodium deoxycholate and dimyristoylphosphatidylcholine mixed micelles. J Phys Chem B. 2008;112:3997–4008.
100. Morales JO, Montenegro-Nicolini M, Campano-Hantscheruk F. Forma farmacéutica para administración bucal de dosis altamente controlada, liberación controlada y estable de biomacromolécula que comprende película polimérica como sustrato de impresión y una tinta de inyección impresa sobre dicha película polimérica que comprende nanoparticulas o suspensiones de nanopartículas con dicha biomacromolécula, y método de preparación.
101. Şenel S, Hıncal AA. Drug permeation enhancement via buccal route: possibilities and limitations. J Control Release. 2001;72:133–44.
102. Caon T, Jin L, Simões CMO, Norton RS, Nicolazzo JA. Enhancing the buccal mucosal delivery of peptide and protein therapeutics. Pharm Res. 2014. doi:10.1007/s11095-014-1485-1.
103. Aungst BJ, Rogers NJ, Shefter E. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J Pharmacol Exp Ther. 1988;244:23–7.
104. Samstein RM, Perica K, Balderrama F, Look M, Fahmy TM. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials. 2008;29:703–8.
105. Gandhi R, Robinson J. Mechanisms of penetration enhancement for transbuccal delivery of salicylic acid. Int J Pharm. 1992;85:129–40.
106. Gupta V, Hwang BH, Doshi N, Mitragotri S. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine. J Control Release. 2013;172:541–9.
107. Hoogstraate AJ, Coos Verhoef J, Pijpers A, van Leengoed LA, Verheijden JH, Junginger HE, et al. In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. Pharm Res. 1996;13:1233–7.
108. Golden GM, McKie JE, Potts RO. Role of stratum corneum lipid fluidity in transdermal drug flux. J Pharm Sci. 1987;76:25–8.
109. Francoeur ML, Golden GM, Potts RO. Oleic acid: its effects on stratum corneum in relation to (trans)dermal drug delivery. Pharm Res. 1990;7:621–7.
110. Morishita M, Barichello JM, Takayama K, Chiba Y, Tokiwa S, Nagai T. Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin. Int J Pharm. 2001;212:289–93.
111. Tsutsumi K, Obata Y, Takayama K, Loftsson T, Nagai T. Effect of cod-liver oil extract on the buccal permeation of ergotamine tartrate. Drug Dev Ind Pharm. 1998;24:757–62.
112. Khutoryanskiy VV. Advances in mucoadhesion and mucoadhesive polymers. Macromol Biosci. 2011;11:748–64.
113. Carvalho FC, Bruschi ML, Evangelista RC, Gremião MPD. Mucoadhesive drug delivery systems. Braz J Pharm Sci. 2010;46:1–17.
114. Shaikh R, Raj Singh TR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bio Sci. 2011;3:89–100.
115. Mythri G, Kavitha K, Kumar MR, Singh SJ, others. Novel mucoadhesive polymers–a review. 2011.
116. Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci. 1999;2:53–61.
117. Su Cha D, Choi JH, Chinnan MS, Park HJ. Antimicrobial films based on Na-alginate and κ-carrageenan. LWT—Food Sci Technol. 2002;35:715–9.
118. Patel VM, Prajapati BG, Patel MM. Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design. AAPS PharmSciTech. 2007;8:E119–26.
119. Rathbone M, Senel S, Pather I. Oral mucosal drug delivery and therapy. Springer: New York Heidelberg Dordrecht London; 2015.
120. Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release. 1985;2:257–75.
121. Senel S, Kremer MJ, Kaş S, Wertz PW, Hincal AA, Squier CA. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials. 2000;21:2067–71.
122. Portero A, Remuñán-López C, Nielsen HM. The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model-an in vitro model of the buccal epithelium. Pharm Res. 2002;19:169–74.
123. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57:1595–639.
124. Priya S, Rathnanand M, Nayanabhirama U, Ongole R. Preparation and evaluation of buccal mucoadhesive patch of betamethasone sodium posphate for the treatment of oral submucous fibrosis. J Chem Pharm Res. 2011;3:56–65.
125. Nagaraju T, Gowthami R, Rajashekar M, Sandeep S, Mallesham M, Sathish D, et al. Comprehensive review on oral disintegrating films. Curr Drug Deliv. 2013;10:96–108.
126. Kumar V, Chari R, Sharma VK, Kalonia DS. Modulation of the thermodynamic stability of proteins by polyols: significance of polyol hydrophobicity and impact on the chemical potential of water. Int J Pharm. 2011;413:19–28.
127. Liu X, Zhou P, Tran A, Labuza TP. Effects of polyols on the stability of whey proteins in intermediate-moisture food model systems. J Agric Food Chem. 2009;57:2339–45.